LONG-TERM SAFETY OF USTEKINUMAB IN IBD PATIENTS WITH A HISTORY OF BIOLOGIC FAILURE: POOLED SAFETY ANALYSIS THROUGH 5 YEARS IN CROHN’S DISEASE AND 2 YEARS IN ULCERATIVE COLITIS

Subrata Ghosh  ¹     Scott Lee  ²     Remo Panaccione  ³     Elyssa Ott  ⁴     Christopher Gasink  ⁴     Ye Miao  ⁵     Colleen W. Marano  ^5    
1 University College Cork, Birmingham, Ireland
² University of Washington Medical Center, Seattle, United States
³ University of Calgary, Calgary, Canada
⁴ Janssen Scientific Affairs, LLC, Horsham, United States
⁵ Janssen Research & Development, LLC, Spring House

Session
Safety and emergencies in lower GI disease (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)